癌症研究
免疫系统
免疫疗法
肿瘤微环境
医学
流式细胞术
癌症免疫疗法
癌症
原肌球蛋白受体激酶A
癌细胞
免疫组织化学
生物
细胞
T细胞
疾病
免疫检查点
免疫学
抗原
黑色素瘤
生物标志物
抗体
车站3
质量细胞仪
转移
病态的
渗透(HVAC)
炎症
内化
受体
细胞生长
泛素
分泌物
神经细胞
实验病理学
神经生长因子
作者
Tianlu Jiang,Peng Zhou,Yi Shen,Jie Lin,Ying Li,Xusheng Shen,Lang Fang,Penghui Xu,Zekuan Xu,Linjun Wang,Yiwen Xia
标识
DOI:10.1186/s43556-026-00444-1
摘要
Gastric cancer (GC) remains a leading cause of cancer-related morbidity and mortality worldwide. Neural invasion (NI) is a common pathological behavior that worsens the prognosis in GC. However, the immune microenvironment of neural invasion-positive GC (NI + GC) and its potential therapeutic implications remain poorly defined. Here, we performed single-cell RNA sequencing (scRNA-seq) on tumor specimens from patients with NI + GC and neural invasion-negative GC (NI − GC) to comprehensively delineate the immune landscape. Our analysis revealed a significant enrichment of exhausted ANXA1 + CD8 + T cells within NI + GC tissues, which was validated by flow cytometry and multiplex immunohistochemistry assays. Clinically, patients with greater infiltration of ANXA1 + CD8 + T cells had worse overall survival and disease progression. Mechanistically, ANXA1 bound to TRKA via N-terminal region, blocking NEDD4L-mediated ubiquitination and degradation of TRKA, thereby suppressing glycolytic metabolism and driving CD8⁺T cell exhaustion. Tumor-derived nerve growth factor (NGF) further amplified this exhaustion via TRKA engagement. Importantly, treatment with an ANXA1-derived peptide (A11) combined with TRKA inhibitors synergistically reversed T cell exhaustion and suppressed tumor growth in preclinical models. These findings unveil distinctive features of the immune microenvironment in NI + GC and elucidate the underlying molecular mechanisms of ANXA1/TRKA axis in facilitating immune evasion, which offer new insights for enhancing the sensitivity of immunotherapy to NI + GC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI